As a result of the mandates


Published on

A presentation about UK PubMed Central, given at the Research Information Network / Repositories Support Project event in London, 29th May, 2009.

The presentation outlines the benefits of using the UKPMC service to the UK's biomedical and health research community, which include increasing visibility. It also provides an overview of some of the development activities being undertaken by the UKPMC development team.

Published in: Health & Medicine, Technology
1 Like
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

As a result of the mandates

  1. 1. As a result of the mandates Research in the open How mandates work in practice 29 th May, 2009 Paul Davey, UK PubMed Central Engagement Manager, British Library
  2. 2. A little background <ul><ul><ul><ul><li>Aim is to become the information resource of choice for the UK’s biomedical and health research community </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Supported from biomedical and health research organisations and government bodies </li></ul></ul></ul></ul><ul><ul><ul><ul><li>£1.2 million development programme </li></ul></ul></ul></ul>
  3. 3. Common principles of our funders <ul><li>Freely available </li></ul><ul><li>‘ Make freely available research outputs arising from biomedical and health funded research…. </li></ul><ul><li>Added to UK PubMed Central </li></ul><ul><li>… Electronic copies of any biomedical research papers accepted for publication made available in UK PubMed Central…. </li></ul><ul><li>Freely copied and reused </li></ul><ul><li>… Authors and publishers, if an open access fee has been paid, to licence research papers such that they may be freely copied and re-used for purposes such as text and data mining, provided that such uses are fully attributed. This is also encouraged where no fee has been paid.’ </li></ul>
  4. 4. An example: Department of Health view <ul><ul><ul><li>Research Government framework – clear government policy to provide free access to research being undertaken and its findings (following appropriate review) </li></ul></ul></ul><ul><ul><ul><li>Preservation of research outputs for current, and future, generations to access </li></ul></ul></ul><ul><ul><ul><li>Electronic copies of any research papers accepted for publication must be submitted to UK PubMed Central within six months of publication </li></ul></ul></ul><ul><ul><ul><li>Links to ALL funder’s open access policies can be found at </li></ul></ul></ul>
  5. 5. A few facts and figures <ul><li>Around 99.5% of papers submitted are taken care of by the publishers </li></ul><ul><li>Remaining 0.5% or so (final copy of the manuscript) are submitted by PIs, or colleagues </li></ul><ul><li>Compliance is steadily increasing, as funder’s policies kick in (these were by and large instigated with grants awarded from 2007) </li></ul><ul><li>1.6 million+ papers in UK PubMed Central </li></ul><ul><li>Downloads are increasing – from 42,646 in May 2008 </li></ul><ul><li> to 366,030 in April 2009 </li></ul>
  6. 6. <ul><li>A growing archive of peer-reviewed research papers, accessible by everyone, anywhere, free. </li></ul><ul><li>Some core benefits </li></ul><ul><li>Transparency and cutting down potential duplication– could even help advance scientific research </li></ul><ul><li>Brings greater visibility to researchers and their work </li></ul><ul><li>Additional benefits </li></ul><ul><li>The articles enable us to work with researchers and funders Developing useful, exciting and innovative tools and services </li></ul> So, as a result of the mandates, we have…
  7. 7. Tools / services: exploiting the literature <ul><li>With the research articles the aim is to: </li></ul><ul><li>Enable researchers to exploit the scientific literature, by linking to other relevant life sciences databases…reached through EBI’s CiteXplore ( ) </li></ul><ul><li>To ensure relevance, we could work from top level assumption that biomedical and health research scientists are broadly interested in three areas: </li></ul><ul><li>Chemistry </li></ul><ul><li>Medicine </li></ul><ul><li>Biology </li></ul><ul><li>(Dietrich Rebholz-Schuman, MD, PhD, Leader - Rebholz Group, European Bioinformatics Institute, May 2009) </li></ul>
  8. 8. Cell type Drug dosage Chemicals Method Protein / Gene Chemical part: methods section
  9. 9. Biological part: drugs acting on proteins Drug (cause) Protein / Gene
  10. 10. Drug (cause) Cell type Disease type Medical part: growth of prostate cancer cells
  11. 11. Tools / services: Identifying and adding content <ul><li>Identifying and providing access to a wide-range of additional, valuable content, such as clinical guidelines, theses and single issue research reports </li></ul><ul><li>- E.g. we are ingesting National Institute for Health and Clinical Excellence guidelines </li></ul>
  12. 12. Tools / services: Grant Lookup
  13. 13. Tools / services: Grant reporting and other features
  14. 14. Grant reporting – My UKPMC
  15. 15. My UKPMC: Specific features for users
  16. 16. New, intuitive, user tested interface
  17. 17. In summary <ul><ul><ul><ul><li>We have the backing of key funders in the UK </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Our developments will enable researchers to become more efficient and effective </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Researcher’s visibility will increase, whilst cutting down on duplication </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Developing a resource with a UK identity and the needs of our community in mind, whilst building upon the world-wide recognition of PubMed Central in the United States </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Beta site: October 2009 </li></ul></ul></ul></ul><ul><ul><ul><ul><li>Anticipated launch of new website: January 2010 </li></ul></ul></ul></ul><ul><ul><ul><li>Contact: [email_address] </li></ul></ul></ul><ul><ul><ul><li>UK PubMed Central Engagement Manager </li></ul></ul></ul>